Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial

被引：0
|
作者：
Foa, A. Alberto [1 ]
Claggett, B. L. [1 ]
Miao, M. [1 ]
Pabon, M. [1 ]
Lu, H. [1 ]
Pfeffer, M. A. [1 ]
Packer, M. [2 ]
Rouleau, J. L. [3 ]
Lefkowitz, M. [4 ]
Desai, A. S. [1 ]
Mcmurray, J. J. V. [5 ]
Solomon, S. D. [1 ]
Vaduganathan, M. [1 ]
机构：
[1] Harvard Med Sch, Brigham & WomenS Hosp, Boston, MA 02115 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[3] Univ Montreal, Cardiol, Montreal, PQ, Canada
[4] Novartis, E Hanover, NJ USA
[5] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：225 / 226
页数：2
相关论文
共 46 条
  • [1] Effect of sacubitril/valsartan on cognitive function in patients with HFpEF: a prespecified analysis of PARAGON-HF
    Dewan, P.
    Jhund, P. S.
    Anand, I. S.
    Desai, A. S.
    Gong, J.
    Lefkowitz, M. P.
    Pieske, B.
    Rizkala, A. R.
    Shah, S. J.
    Van Veldhuisen, D. J.
    Zannad, F.
    Zile, M. R.
    Solomon, S. D.
    McMurray, J. J., V
    EUROPEAN HEART JOURNAL, 2020, 41 : 873 - 873
  • [2] How many real world HFpEF patients would be suitable for sacubitril/valsartan treatment according to the PARAGON-HF trial
    Hage, C. Camilla
    Savarese, G.
    Benson, L.
    Donal, E.
    Lundberg, A.
    Daubert, J. C.
    Oger, E.
    Linde, C.
    Lund, L. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 92 - 92
  • [3] The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
    Gronda, Edoardo
    Vanoli, Emilio
    Iacoviello, Massimo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0L) : L77 - L81
  • [4] Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial
    Lund, Lars H.
    Savarese, Gianluigi
    Venkateshvaran, Ashwin
    Benson, Lina
    Lundberg, Anna
    Donal, Erwan
    Daubert, Jean-Claude
    Oger, Emmanuel
    Linde, Cecilia
    Hage, Camilla
    ESC HEART FAILURE, 2022, 9 (01): : 164 - 177
  • [5] Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event
    Mentz, Robert J.
    Ward, Jonathan H.
    Hernandez, Adrian F.
    Lepage, Serge
    Morrow, David A.
    Sarwat, Samiha
    Sharma, Kavita
    Solomon, Scott D.
    Starling, Randall C.
    Velazquez, Eric J.
    Williamson, Kristin
    Zieroth, Shelley
    Braunwald, Eugene
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (06) : 922 - 930
  • [6] EFFECTS OF SACUBITRIL/VALSARTAN OR VALSARTAN IN DE NOVO VS. CHRONIC HFPEF AND HFMREF: THE PARAGLIDE-HF TRIAL
    Murray, Evan
    Cyr, Derek D.
    Morrow, David A.
    Starling, Randall C.
    Zieroth, Shelley R.
    Hernandez, Adrian F.
    Williamson, Kristin
    Lepage, Serge
    Fudim, Marat
    Desai, Akshay S.
    Ward, Jonathan
    Solomon, Scott D.
    Mentz, Robert John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4607 - 4607
  • [7] Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trial
    Lu, Henri
    Claggett, Brian L.
    Packer, Milton
    Pfeffer, Marc A.
    Lam, Carolyn S. P.
    Zile, Michael R.
    Desai, Akshay S.
    Jhund, Pardeep
    Lefkowitz, Martin
    Mcmurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2025, 27 (01) : 85 - 95
  • [8] Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
    Magnus O. Wijkman
    Brian Claggett
    Muthiah Vaduganathan
    Jonathan W. Cunningham
    Rasmus Rørth
    Alice Jackson
    Milton Packer
    Michael Zile
    Jean Rouleau
    Karl Swedberg
    Martin Lefkowitz
    Sanjiv J. Shah
    Marc A. Pfeffer
    John J. V. McMurray
    Scott D. Solomon
    Cardiovascular Diabetology, 21
  • [9] SACUBITRIL/VALSARTAN, TREATMENT-RELATED HYPOTENSION, AND LEFT VENTRICULAR EJECTION FRACTION IN THE PARAGON-HF TRIAL
    Foa, Alberto
    Claggett, Brian
    Pabon, Maria
    Lu, Henri
    Pfeffer, Marc A.
    Packer, Milton
    Vardeny, Orly
    Rouleau, Jean L.
    Lefkowitz, Martin
    Jhund, Pardeep S.
    Desai, Akshay S.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 376 - 376
  • [10] Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial
    Chatur, Safia
    Claggett, Brian L.
    Vardeny, Orly
    Jering, Karola
    Desai, Akshay S.
    Pfeffer, Marc A.
    Lefkowitz, Martin
    McMurray, John J., V
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (01) : 87 - 94
12345